Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00559013 · ClinicalTrials.gov registry record · NA

Peri-Strips Dry (PSD) Veritas Collagen Matrix Staple Line Reinforcement for Colorectal Surgery

A NA study, sponsored by Baxter Healthcare Corporation.

Completed
Registry status
NA
Development phase
38
Enrollment target

NCT00559013: Completed NA study, sponsored by Baxter Healthcare Corporation.

NCT00559013 is a NA study that has completed, run by Baxter Healthcare Corporation. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00559013, a NA study, has completed, sponsored by Baxter Healthcare Corporation.

COMPLETED
Registry status
NA
Development phase
38 participants
Enrollment target

Study Summary

Purpose of the study is to assess the utility of PSD Veritas as a staple line reinforcement to minimize the risk of leakage during or after colo-rectal surgery.

Interventions

  • DEVICE Staple line reinforcement

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2007-03
Est. Completion 2008-12
Phase NA
Baxter Healthcare Corporation

46 total trials

What the finished NCT00559013 record still lists

NCT00559013 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Staple line reinforcement is the first listed.

NCT00559013 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00559013 about?

NCT00559013 is a clinical study titled "Peri-Strips Dry (PSD) Veritas Collagen Matrix Staple Line Reinforcement for Colorectal Surgery". Purpose of the study is to assess the utility of PSD Veritas as a staple line reinforcement to minimize the risk of leakage during or after colo-rectal surgery.

What is the current status of trial NCT00559013?

This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2007-03. Estimated completion is 2008-12.

What interventions are being tested in trial NCT00559013?

The interventions under investigation include: Staple line reinforcement (DEVICE).

Who is sponsoring clinical trial NCT00559013?

This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00559013's enrollment target sits among peer trials

38 1538th of 2000 higher than 461 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01684904 · 38 participants · NA

    Proton Therapy for Esophageal Cancer

  • NCT03310879 · 38 participants · Phase 2

    Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6

  • NCT03896269 · 38 participants · Phase 1

    CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

  • NCT04085315 · 38 participants · Phase 1

    Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00559013, the US trial registry maintained by the National Library of Medicine. NCT00559013 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.